A biochemist and immunologist with 37 years of experience in the biotechnology industry developing innovative cancer drugs provides an insider’s perspective of how immunotherapy and other astonishing new cancer medicines are improving both the quality and duration of patient's lives and, for the most fortunate, totally eradicating their tumors, thereby achieving the Holy Grail of cancer medicine: the long-sought cure for cancer.